Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
2.790
-0.040 (-1.41%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Puma Biotechnology Revenue

Puma Biotechnology had revenue of $47.08M in the quarter ending June 30, 2024, a decrease of -13.72%. This brings the company's revenue in the last twelve months to $219.14M, down -4.77% year-over-year. In the year 2023, Puma Biotechnology had annual revenue of $235.64M with 3.34% growth.

Revenue (ttm)
$219.14M
Revenue Growth
-4.77%
P/S Ratio
0.61
Revenue / Employee
$1,184,557
Employees
185
Market Cap
136.84M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023235.64M7.61M3.34%
Dec 31, 2022228.03M-25.12M-9.92%
Dec 31, 2021253.16M28.05M12.46%
Dec 31, 2020225.11M-47.15M-17.32%
Dec 31, 2019272.26M21.27M8.47%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
InfuSystem Holdings 129.37M
Akoya Biosciences 93.22M
Verastem 10.00M
Avalo Therapeutics 807.00K
Cardiff Oncology 665.00K
INmune Bio 85.00K
Kazia Therapeutics 382.00
Revenue Rankings